CRL Logo

Charles River Laboratories International, Inc. (CRL) 

NYSE
Market Cap
$11.04B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
98 of 776
Rank in Industry
4 of 42

Largest Insider Buys in Sector

CRL Stock Price History Chart

CRL Stock Performance

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also …

Insider Activity of Charles River Laboratories International, Inc.

Over the last 12 months, insiders at Charles River Laboratories International, Inc. have bought $1.25M and sold $15.96M worth of Charles River Laboratories International, Inc. stock.

On average, over the past 5 years, insiders at Charles River Laboratories International, Inc. have bought $1.28M and sold $34.74M worth of stock each year.

Highest buying activity among insiders over the last 12 months: FOSTER JAMES C (Chairman, President and CEO) — $1M. Girshick Birgit (Corporate Executive VP & COO) — $248,298.

The last purchase of 1,322 shares for transaction amount of $248,298 was made by Girshick Birgit (Corporate Executive VP & COO) on 2023‑11‑20.

List of Insider Buy and Sell Transactions, Charles River Laboratories International, Inc.

2024-08-08SaleEVP, Corp Strategy & Develop
1,780
0.0034%
$199.36$354,861-3.59%
2024-08-01SaleChairman, President and CEO
25,000
0.05%
$250.00$6.25M-18.89%
2024-05-15Saledirector
332
0.0007%
$235.62$78,225-11.89%
2024-05-10SaleEVP, Corp Strategy & Develop
1,304
0.0025%
$226.97$295,969-9.70%
2024-03-08SaleCSVP&Chief Accounting Officer
808
0.0016%
$267.52$216,156-19.55%
2024-03-04SaleCSVP&Chief Accounting Officer
2,750
0.0054%
$261.05$717,890-16.11%
2024-02-29SaleEVP & Chief People Officer
5,000
0.0097%
$253.70$1.27M-14.41%
2024-02-29SaleCEVP, Disc & Safety Assessment
3,786
0.0073%
$253.45$959,545-14.41%
2024-02-22SaleCorporate Executive VP & CCO
4,050
0.0079%
$248.50$1.01M-11.36%
2024-02-15SaleEVP, Corp Strategy & Develop
838
0.0016%
$238.93$200,223-9.72%
2024-02-15SaleCEVP, Disc & Safety Assessment
5,882
0.0113%
$241.20$1.42M-9.72%
2023-12-14SaleEVP & Chief People Officer
5,526
0.0106%
$225.00$1.24M-2.74%
2023-11-30SaleEVP, Corp Strategy & Develop
1,850
0.0036%
$197.73$365,801+11.92%
2023-11-20PurchaseCorporate Executive VP & COO
1,322
0.0025%
$187.82$248,298+14.58%
2023-11-14PurchaseChairman, President and CEO
5,620
0.0109%
$178.05$1M+21.99%
2023-11-09SaleEVP, Corp Strategy & Develop
9,128
0.0182%
$173.48$1.58M+28.99%
2023-08-24Purchasedirector
1,000
0.0019%
$198.79$198,786+8.50%
2023-08-10SaleEVP, Corp Strategy & Develop
700
0.0014%
$216.52$151,564-1.30%
2023-08-10SaleCSVP&Chief Accounting Officer
1,471
0.0029%
$216.54$318,530-1.30%
2023-08-10SaleCorporate Executive VP & CCO
5,763
0.0113%
$217.24$1.25M-1.30%

Insider Historical Profitability

5.8%
FOSTER JAMES CChairman, President and CEO
188251
0.3646%
$213.81684+4.13%
Girshick BirgitCorporate Executive VP & COO
44449
0.0861%
$213.81113
GILLETT NANCYCorporate Executive VP
11034
0.0214%
$213.81141+0.49%
Ho John CSenior Vice President
8950
0.0173%
$213.8110+15.04%
WALLMAN RICHARD Fdirector
1000
0.0019%
$213.81412+7.27%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.64B11.746.05M+1.11%+$17.93M0.03
BlackRock$1.4B10.045.17M+0.2%+$2.82M0.03
State Street$567.4M4.072.09M+1.67%+$9.3M0.02
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$508.74M3.651.88M+7.09%+$33.7M1.18
ClearBridge Investments$409.98M2.941.51M+3.07%+$12.21M0.33
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.